Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T L Whiteside

Showing results (11-20 of 346) with videos related to

Pageof 35
Sort By:
Biotherapy (Dordrecht, Netherlands)|January 1, 1992
Tumor-infiltrating lymphocytes as antitumor effector cellsT L Whiteside
Current Oncology Reports|December 21, 2000
Immunobiology and immunotherapy of head and neck cancerT L Whiteside
Archives of Otolaryngology--Head & Neck Surgery|November 11, 1999
Antibody-coated suture enhances immune response: important ideas emerge from multidisciplinary trainingT L Whiteside
Advances in Experimental Medicine and Biology|February 23, 1999
Immune cells in the tumor microenvironment. Mechanisms responsible for functional and signaling defectsT L Whiteside
Clinical Immunology and Immunopathology|June 1, 1994
Symposium-in-writing. IntroductionT L Whiteside
Clinical Immunology and Immunopathology|June 1, 1994
Concluding comments: immunologic intervention in therapy of cancerT L Whiteside
Current Protocols in Immunology|April 25, 2008
Measurement of cytotoxic activity of NK/LAK cellsT L Whiteside
Current Protocols in Immunology|April 25, 2008
Isolation of human NK cells and generation of LAK activityT L Whiteside
Developments in Biologicals|December 18, 2004
Methods to monitor immune response and quality controlT L Whiteside
Clinical and Diagnostic Laboratory Immunology|May 9, 2000
Monitoring of antigen-specific cytolytic T lymphocytes in cancer patients receiving immunotherapyT L Whiteside
Pageof 35

Showing results (11-20 of 346) with videos related to

Sort By:
Pageof 35
Biotherapy (Dordrecht, Netherlands)|January 1, 1992
Tumor-infiltrating lymphocytes as antitumor effector cellsT L Whiteside
Current Oncology Reports|December 21, 2000
Immunobiology and immunotherapy of head and neck cancerT L Whiteside
Archives of Otolaryngology--Head & Neck Surgery|November 11, 1999
Antibody-coated suture enhances immune response: important ideas emerge from multidisciplinary trainingT L Whiteside
Advances in Experimental Medicine and Biology|February 23, 1999
Immune cells in the tumor microenvironment. Mechanisms responsible for functional and signaling defectsT L Whiteside
Clinical Immunology and Immunopathology|June 1, 1994
Symposium-in-writing. IntroductionT L Whiteside
Clinical Immunology and Immunopathology|June 1, 1994
Concluding comments: immunologic intervention in therapy of cancerT L Whiteside
Current Protocols in Immunology|April 25, 2008
Measurement of cytotoxic activity of NK/LAK cellsT L Whiteside
Current Protocols in Immunology|April 25, 2008
Isolation of human NK cells and generation of LAK activityT L Whiteside
Developments in Biologicals|December 18, 2004
Methods to monitor immune response and quality controlT L Whiteside
Clinical and Diagnostic Laboratory Immunology|May 9, 2000
Monitoring of antigen-specific cytolytic T lymphocytes in cancer patients receiving immunotherapyT L Whiteside
Pageof 35